Depleted uranium (DU; also referred to in the past as Q-metal, depletalloy or D-38) is uranium with a lower content of the fissile isotope U-235 than natural uranium. Natural uranium contains about 0.72% U-235, while the DU used by the U.S. Department of Defense contains 0.3% U-235 or less. Uses of DU take advantage of its very high density of 19.1 g/cm3 (68.4% denser than lead). The less radioactive and non-fissile uranium-238 constitutes the main component of depleted uranium.
Civilian uses include counterweights in aircraft, radiation shielding in medical radiation therapy and industrial radiography equipment, and containers for transporting radioactive materials. Military uses include armor plating and armor-piercing projectiles.
Most depleted uranium arises as a by-product of the production of enriched uranium for use as fuel in nuclear reactors and in the manufacture of nuclear weapons. Enrichment processes generate uranium with a higher-than-natural concentration of lower-mass-number uranium isotopes (in particular U-235, which is the uranium isotope supporting the fission chain reaction) with the bulk of the feed ending up as depleted uranium, in some cases with mass fractions of U-235 and U-234 less than a third of those in natural uranium. Since U-238 has a much longer half-life than the lighter isotopes, DU emits less alpha radiation than natural uranium. DU from nuclear reprocessing has different isotopic ratios from enrichment–by-product DU, from which it can be distinguished by the presence of U-236.
DU used in US munitions has 60% of the radioactivity of natural uranium. Trace transuranics (another indicator of the use of reprocessed material) have been reported to be present in some US tank armor.
The use of DU in munitions is controversial because of concerns about potential long-term health effects. Normal functioning of the kidney, brain, liver, heart, and numerous other systems can be affected by exposure to uranium, a toxic metal. It is only weakly radioactive because of its long radioactive half-life (4.468 billion years for uranium-238, 700 million years for uranium-235; or 1 part per million every 6446 and 1010 years, respectively). The biological half-life (the average time it takes for the human body to eliminate half the amount in the body) for uranium is about 15 days. The aerosol or spallation frangible powder produced by impact and combustion of depleted uranium munitions can potentially contaminate wide areas around the impact sites, leading to possible inhalation by human beings.
The actual level of acute and chronic toxicity of DU is also controversial. Several studies using cultured cells and laboratory rodents suggest the possibility of leukemogenic, genetic, reproductive, and neurological effects from chronic exposure. A 2005 epidemiology review concluded: "In aggregate the human epidemiological evidence is consistent with increased risk of birth defects in offspring of persons exposed to DU."
Enriched uranium was first manufactured in the early 1940s when the United States and Britain began their nuclear weapons programs. Later in the decade, France and the Soviet Union began their nuclear weapons and nuclear power programs. Depleted uranium was originally stored as an unusable waste product (uranium hexafluoride) in the hope that improved enrichment processes could extract additional quantities of the fissionable U-235 isotope. This re-enrichment recovery of the residual uranium-235 is now in practice in some parts of the world; e.g. in 1996 over 6000 metric tonnes were upgraded in a Russian plant.
It is possible to design civilian power-generating reactors using unenriched fuel, but only about 10% of those ever built (such as the CANDU reactor) utilize that technology. Thus most civilian reactors as well as all naval reactors and nuclear weapons production require fuel containing concentrated U-235 and generate depleted Uranium.
In the 1970s, the Pentagon reported that the Soviet military had developed armor plating for Warsaw Pact tanks that NATO ammunition could not penetrate. The Pentagon began searching for material to make denser armor-piercing projectiles. After testing various metals, ordnance researchers settled on depleted uranium.
The US and NATO militaries used DU penetrator rounds in the 1991 Gulf War, the Bosnia war, bombing of Serbia, the 2003 invasion of Iraq, and 2015 airstrikes on ISIS in Syria. It is estimated that between 315 and 350 tons of DU were used in the 1991 Gulf War.
Production and availabilityEdit
Natural uranium metal contains about 0.71% U-235, 99.28% U-238, and about 0.0054% U-234. The production of enriched uranium using isotope separation creates depleted uranium containing only 0.2% to 0.4% U-235. Because natural uranium begins with such a low percentage of U-235, enrichment produces large quantities of depleted uranium. For example, producing 1 kg of 5% enriched uranium requires 11.8 kg of natural uranium, and leaves about 10.8 kg of depleted uranium having only 0.3% U-235.
The Nuclear Regulatory Commission (NRC) defines depleted uranium as uranium with a percentage of the 235U isotope that is less than 0.711% by weight (see 10 CFR 40.4). The military specifications designate that the DU used by the U.S. Department of Defense (DoD) contain less than 0.3% 235U (AEPI, 1995). In actuality, DoD uses only DU that contains approximately 0.2% 235U (AEPI, 1995).
Depleted uranium is further produced by recycling spent nuclear fuel, in which case it contains traces of neptunium and plutonium. Quantities are so small that they are considered to be not of serious radiological significance (even) by ECRR.
Most depleted uranium is stored as uranium hexafluoride, a toxic crystalline solid, (D)UF6, in steel cylinders in open air storage yards close to enrichment plants. Each cylinder holds up to 12.7 tonnes (14 short tons) of UF6. In the U.S. 560,000 tonnes of depleted UF6 had accumulated by 1993. In 2008, 686,500 tonnes in 57,122 storage cylinders were located near Portsmouth, Ohio; Oak Ridge, Tennessee; and Paducah, Kentucky.
The storage of DUF6 presents environmental, health, and safety risks because of its chemical instability. When UF6 is exposed to water vapor in the air, it reacts with the moisture to produce UO2F2 (uranyl fluoride), a solid, and HF (hydrogen fluoride), a gas, both of which are highly soluble and toxic. The uranyl fluoride solid acts to plug the leak, limiting further escape of depleted UF6. Release of the hydrogen fluoride gas to the atmosphere is also slowed by the plug formation. Storage cylinders are regularly inspected for signs of corrosion and leaks, and are repainted and repaired as necessary.
A tenfold jump in uranium prices has transformed approximately one-third of the U.S. depleted uranium inventory into an asset worth $7.6 billion, assuming DOE re-enriches it. This estimate is based on February 2008 market price for uranium and enrichment services, and DOE's access to sufficient uranium enrichment capacity.
There have been several accidents involving uranium hexafluoride in the United States, including one in which 32 workers were exposed to a cloud of UF6 and its reaction products. One person died; while a few workers with higher exposure experienced short-term kidney damage (e.g., protein in the urine), none of them showed lasting damage from the exposure to uranium. The U.S. government has been converting depleted UF6 to solid uranium oxides for use or disposal. Such disposal of the entire DUF6 inventory could cost anywhere from $15 million to $450 million.
|Country||Organization||Estimated DU stocks
|Singapore||DSO National Laboratories||60||2007|
Depleted uranium is very dense; at 19,050 kg/m³, it is 1.67 times as dense as lead, only slightly less dense than tungsten and gold, and 84% as dense as osmium or iridium, which are the densest known substances under standard (i.e., Earth-surface) pressures. Consequently, a DU projectile of given mass has a smaller diameter than an equivalent lead projectile, with less aerodynamic drag and deeper penetration due to a higher pressure at point of impact. DU projectile ordnance is often inherently incendiary because uranium is flammable.
Because of its high density, depleted uranium can also be used in tank armor, sandwiched between sheets of steel armor plate. For instance, some late-production M1A1HA and M1A2 Abrams tanks built after 1998 have DU modules integrated into their Chobham armor, as part of the armor plating in the front of the hull and the front of the turret, and there is a program to upgrade the rest.
Most military use of depleted uranium has been as 30 mm ordnance, primarily the 30 mm PGU-14/B armour-piercing incendiary round from the GAU-8 Avenger cannon of the A-10 Thunderbolt II used by the United States Air Force. 25 mm DU rounds have been used in the M242 gun mounted on the U.S. Army's Bradley Fighting Vehicle and the Marine Corps's LAV-25.
The U.S. Marine Corps uses DU in the 25 mm PGU-20 round fired by the GAU-12 Equalizer cannon of the AV-8B Harrier, and also in the 20 mm M197 gun mounted on AH-1 Cobra helicopter gunships. The United States Navy's Phalanx CIWS's M61 Vulcan Gatling gun used 20 mm armor-piercing penetrator rounds with discarding plastic sabots and a core made using depleted uranium, later changed to tungsten.
Another use of depleted uranium is in kinetic energy penetrators, anti-armor rounds such as the 120 mm sabot rounds fired from the British Challenger 1, Challenger 2, M1A1 and M1A2 Abrams. Kinetic energy penetrator rounds consist of a long, relatively thin penetrator surrounded by a discarding sabot. Staballoys are metal alloys of depleted uranium with a very small proportion of other metals, usually titanium or molybdenum. One formulation has a composition of 99.25% by mass of depleted uranium and 0.75% by mass of titanium. Staballoys are approximately 1.67 times as dense as lead and are designed for use in kinetic energy penetrator armor-piercing ammunition. The US Army uses DU in an alloy with around 3.5% titanium.
According to 2005 research, at least some of the most promising tungsten alloys that have been considered as replacement for depleted uranium in penetrator ammunitions, such as tungsten-cobalt or tungsten-nickel-cobalt alloys, also possess carcinogenic properties: rats implanted with a pellet of such alloys developed lethal rhabdomyosarcoma within a few weeks.
Depleted uranium is favored for the penetrator because it is self-sharpening and flammable. On impact with a hard target, such as an armored vehicle, the nose of the rod fractures in such a way that it remains sharp. The impact and subsequent release of heat energy causes it to ignite. When a DU penetrator reaches the interior of an armored vehicle, it catches fire, often igniting ammunition and fuel, killing the crew and possibly causing the vehicle to explode. DU is used by the U.S. Army in 120 mm or 105 mm cannons employed on the M1 Abrams tank. The Russian military has used DU ammunition in tank main gun ammunition since the late 1970s, mostly for the 115 mm guns in the T-62 tank and the 125 mm guns in the T-64, T-72, T-80, and T-90 tanks.
The DU content in various ammunition is 180 g in 20 mm projectiles, 200 g in 25 mm ones, 280 g in 30 mm, 3.5 kg in 105 mm, and 4.5 kg in 120 mm penetrators. DU was used during the mid-1990s in the U.S. to make hand grenades, and land mines, but those applications have been discontinued, according to Alliant Techsystems. The US Navy used DU in its 20 mm Phalanx CIWS guns, but switched in the late 1990s to armor-piercing tungsten.
Only the US and the UK have acknowledged using DU weapons.
In a three-week period of conflict in Iraq during 2003, it was estimated that over 1000 tons of depleted uranium munitions were used.
Legal status in weaponsEdit
In 1996, the International Court of Justice (ICJ) gave an advisory opinion on the "legality of the threat or use of nuclear weapons". This made it clear, in paragraphs 54, 55 and 56, that international law on poisonous weapons—the Second Hague Declaration of 29 July 1899, Hague Convention IV of 18 October 1907 and the Geneva Protocol of 17 June 1925—did not cover nuclear weapons, because their prime or exclusive use was not to poison or asphyxiate. This ICJ opinion was about nuclear weapons, but the sentence "The terms have been understood, in the practice of States, in their ordinary sense as covering weapons whose prime, or even exclusive, effect is to poison or asphyxiate," also removes depleted uranium weaponry from coverage by the same treaties as their primary use is not to poison or asphyxiate, but to destroy materiel and kill soldiers through kinetic energy.
The Sub-Commission on Prevention of Discrimination and Protection of Minorities of the United Nations Human Rights Commission, passed two motions — the first in 1996 and the second in 1997. They listed weapons of mass destruction, or weapons with indiscriminate effect, or of a nature to cause superfluous injury or unnecessary suffering and urged all states to curb the production and the spread of such weapons. Included in the list was weaponry containing depleted uranium. The committee authorized a working paper, in the context of human rights and humanitarian norms, of the weapons.
The requested UN working paper was delivered in 2002 by Y. K. J. Yeung Sik Yuen in accordance with Sub-Commission on the Promotion and Protection of Human Rights resolution 2001/36. He argues that the use of DU in weapons, along with the other weapons listed by the Sub‑Commission, may breach one or more of the following treaties: the Universal Declaration of Human Rights, the Charter of the United Nations, the Genocide Convention, the United Nations Convention Against Torture, the Geneva Conventions including Protocol I, the Convention on Conventional Weapons of 1980, and the Chemical Weapons Convention. Yeung Sik Yuen writes in Paragraph 133 under the title "Legal compliance of weapons containing DU as a new weapon":
Annex II to the Convention on the Physical Protection of Nuclear Material 1980 (which became operative on 8 February 1997) classifies DU as a category II nuclear material. Storage and transport rules are set down for that category which indicates that DU is considered sufficiently "hot" and dangerous to warrant these protections. But since weapons containing DU are relatively new weapons no treaty exists yet to regulate, limit or prohibit its use. The legality or illegality of DU weapons must therefore be tested by recourse to the general rules governing the use of weapons under humanitarian and human rights law which have already been analysed in Part I of this paper, and more particularly at paragraph 35 which states that parties to Protocol I to the Geneva Conventions of 1949 have an obligation to ascertain that new weapons do not violate the laws and customs of war or any other international law. As mentioned, the International Court of Justice considers this rule binding customary humanitarian law.
Louise Arbour, chief prosecutor for the International Criminal Tribunal for the Former Yugoslavia led a committee of staff lawyers to investigate possible treaty prohibitions against the use of DU in weapons. Their findings were that:
There is no specific treaty ban on the use of DU projectiles. There is a developing scientific debate and concern expressed regarding the impact of the use of such projectiles and it is possible that, in future, there will be a consensus view in international legal circles that use of such projectiles violate general principles of the law applicable to use of weapons in armed conflict. No such consensus exists at present.
Requests for a moratorium on military useEdit
A number of academics specializing in international humanitarian law have questioned the legality of the continued use of depleted uranium weapons, highlighting that the effects may breach the principle of distinction (between civilians and military personnel). Some states and the International Coalition to Ban Uranium Weapons, a coalition of more than 155 non-governmental organizations, have asked for a ban on the production and military use of depleted uranium weapons.
The European Parliament has repeatedly passed resolutions requesting an immediate moratorium on the further use of depleted uranium ammunition, but France and Britain – the only EU states that are permanent members of the United Nations Security Council – have consistently rejected calls for a ban, maintaining that its use continues to be legal, and that the health risks are unsubstantiated.
In 2007, France, Britain, the Netherlands, and the Czech Republic voted against a United Nations General Assembly resolution to hold a debate in 2009 about the effects of the use of armaments and ammunitions containing depleted uranium. All other European Union nations voted in favour or abstained. The ambassador from the Netherlands explained his negative vote as being due to the reference in the preamble to the resolution "to potential harmful effects of the use of depleted uranium munitions on human health and the environment [which] cannot, in our view, be supported by conclusive scientific studies conducted by relevant international organizations." None of the other permanent members of the United Nations Security Council supported the resolution as China was absent for the vote, Russia abstained and the United States voted against the resolution.
In September 2008, and in response to the 2007 General Assembly resolution, the UN Secretary General published the views of 15 states alongside those of the International Atomic Energy Agency (IAEA) and World Health Organization (WHO). The IAEA and WHO evidence differed little from previous statements on the issue. The report was largely split between states concerned about depleted uranium's use, such as Finland, Cuba, Japan, Serbia, Argentina, and predominantly NATO members, who do not consider the use of depleted uranium munitions problematic.
In December 2008, 141 states supported a resolution requesting that three UN agencies: United Nations Environment Programme (UNEP), WHO and IAEA update their research on the impact of uranium munitions by late 2010 – to coincide with the General Assembly's 65th Session, four voted against, 34 abstained and 13 were absent As before Britain and France voted against the resolution. All other European Union nations voted in favour or abstained: the Netherlands, which voted against a resolution in 2007, voted in favour, as did Finland and Norway, both of which had abstained in 2007, while the Czech Republic, which voted against the resolution in 2007, abstained. The two other states that voted against the resolution were Israel and the United States (both of which voted against in 2007), while as before China was absent for the vote, and Russia abstained.
On 21 June 2009, Belgium became the first country in the world to ban: "inert ammunition and armour that contains depleted uranium or any other industrially manufactured uranium." The move followed a unanimous parliamentary vote on the issue on 22 March 2007. The text of the 2007 law allowed for two years to pass until it came into force. In April 2009, the Belgian Senate voted unanimously to restrict investments by Belgian banks into the manufacturers of depleted uranium weapons.
In September 2009, the Latin American Parliament passed a resolution calling for a regional moratorium on the use, production and procurement of uranium weapons. It also called on the Parlatino's members to work towards an international uranium weapons treaty.
In December 2010, 148 states supported a United Nations' General Assembly resolution calling for the states that use depleted uranium weapons in conflict to reveal where the weapons have been fired when asked to do so by the country upon whose territory they have been used.
In April 2011, the Congress of Costa Rica passed a law prohibiting uranium weapons in its territories, becoming the second country in the world to do so. In November 2010 the Irish Senate passed a bill seeking to outlaw depleted uranium weapons, but it lapsed before approval by the Dáil.
In December 2012, 155 states supported a United Nations' General Assembly resolution that recalled that, because of the ongoing uncertainties over the long-term environmental impacts of depleted uranium identified by the United Nations Environment Programme, states should adopt a precautionary approach to its use.
In December 2014, 150 states supported a United Nations' General Assembly resolution encouraging states to provide assistance to states affected by the use of depleted uranium weapons, in particular in identifying and managing contaminated sites and material. In contrast to the previous biennial resolutions, Germany moved to an abstention from supporting to the resolutions. Prior to the vote, in a report to the United Nations Secretary General requested by 2012's resolution published in June 2014, Iraq had called for a global treaty ban on depleted uranium weapons.
Depleted uranium has a very high density and is primarily used as shielding material for other radioactive material, and as ballast. Examples include sailboat keels, as counterweights and as shielding in industrial radiography cameras.
Shielding in industrial radiography camerasEdit
Industrial radiography cameras include a very high activity gamma radiation source (typically Ir-192 with an activity above 10 TBq). Depleted uranium is often used in the cameras as a shield to protect individuals from the gamma source. Typically, the uranium shield is supported and enclosed in polyurethane foam for thermal, mechanical and oxidation protection.
Coloring in consumer productsEdit
Consumer product uses have included incorporation into dental porcelain, used for false teeth to simulate the fluorescence of natural teeth, and uranium-bearing reagents used in chemistry laboratories (e.g. uranyl acetate, used in analytical chemistry and as a stain in electron microscopy). Uranium (both depleted uranium and natural uranium) was widely used as a coloring matter for porcelain and glass in the 19th and early-to-mid-20th century. The practice was largely discontinued in the late 20th century. In 1999, concentrations of 10% depleted uranium were being used in "jaune no.17" a yellow enamel powder that was being produced in France by Cristallerie de Saint-Paul, a manufacturer of enamel pigments. The depleted uranium used in the powder was sold by Cogéma's Pierrelatte facility. In February 2000, Cogema discontinued the sale of depleted uranium to producers of enamel and glass.
Trim weights in aircraftEdit
Aircraft that contain depleted uranium trim weights for stabilizing wings and control surfaces (such as the Boeing 747–100) may contain between 400 and 1,500 kg of DU. This application is controversial because the DU might enter the environment if the aircraft crashes. The metal can also oxidize to a fine powder in a fire. Its use has been phased out in many newer aircraft. Boeing and McDonnell-Douglas discontinued using DU counterweights in the 1980s. Depleted uranium was released during the crash of El Al Flight 1862 on 4 October 1992, in which 152 kg was lost, but a case study concluded that there was no evidence to link depleted uranium from the plane to any health problems. Counterweights manufactured with cadmium plating are considered non-hazardous while the plating is intact.
US NRC general licenseEdit
US Nuclear Regulatory Commission regulations at 10 CFR 40.25 establish a general license for the use of depleted uranium contained in industrial products or devices for mass-volume applications. This general license allows anyone to possess or use depleted uranium for authorized purposes. Generally, a registration form is required, along with a commitment to not abandon the material. Agreement states may have similar, or more stringent, regulations.
Pen Duick VI, a boat designed by André Mauric and used for racing, was equipped with a keel of depleted uranium. The benefit is that, due to the very high density of uranium, the keel could be thinner for a given weight, and so have less resistance than a normal keel. It was later replaced by a standard lead keel.
Sampling calorimeters for detectors in high-energy particle physicsEdit
Normal functioning of the kidney, brain, liver, heart, and numerous other systems can be affected by uranium exposure because, in addition to being weakly radioactive, uranium is a toxic metal, although less toxic than other heavy metals, such as arsenic and mercury. It is weakly radioactive but is 'persistently' so because of its long half-life. The Agency for Toxic Substances and Disease Registry states that: "to be exposed to radiation from uranium, you have to eat, drink, or breathe it, or get it on your skin." If DU particles do enter an individual, the type of danger presented—toxic vs. radiological—and the organ most likely to be affected depend on the solubility of the particles.
In military conflicts involving DU munitions, the major concern is inhalation of DU particles in aerosols arising from the impacts of DU-enhanced projectiles with their targets. When depleted uranium munitions penetrate armor or burn, they create depleted uranium oxides in the form of dust that can be inhaled or contaminate wounds. The Institute of Nuclear Technology-Radiation Protection of Attiki, Greece, has noted that "the aerosol produced during impact and combustion of depleted uranium munitions can potentially contaminate wide areas around the impact sites or can be inhaled by civilians and military personnel". The utilisation of DU in incendiary ammunition is controversial because of potential adverse health effects and its release into the environment.
The U.S. Department of Defense claims that no human cancer of any type has been seen as a result of exposure to either natural or depleted uranium. Militaries have long had risk-reduction procedures for their troops to follow, and studies are in consistent agreement that veterans who used DU-enhanced munitions have not suffered, so far, from an increased risk of cancer (see the Gulf War and Balkans sections below). The effects of DU on civilian populations are, however, a topic of intense and ongoing controversy.
As early as 1997, British Army doctors warned the Ministry of Defence that exposure to depleted uranium increased the risk of developing lung, lymph and brain cancer, and recommended a series of safety precautions. According to a report issued summarizing the advice of the doctors, "Inhalation of insoluble uranium dioxide dust will lead to accumulation in the lungs with very slow clearance—if any. … Although chemical toxicity is low, there may be localised radiation damage of the lung leading to cancer." The report warns that "All personnel … should be aware that uranium dust inhalation carries a long-term risk … [the dust] has been shown to increase the risks of developing lung, lymph and brain cancers." In 2003, the Royal Society called, again, for urgent attention to be paid to the possible health and environmental impact of depleted uranium, and added its backing to the United Nations Environment Programme's call for a scientific assessment of sites struck with depleted uranium. In early 2004, the UK Pensions Appeal Tribunal Service attributed birth defect claims from a February 1991 Gulf War combat veteran to depleted uranium poisoning. Also, a 2005 epidemiology review concluded: "In aggregate the human epidemiological evidence is consistent with increased risk of birth defects in offspring of persons exposed to DU." Studies using cultured cells and laboratory rodents continue to suggest the possibility of leukemogenic, genetic, reproductive, and neurological effects from chronic exposure.
The chemical toxicity of depleted uranium is about a million times greater in vivo than its radiological hazard, with the kidney considered to be the main target organ. Health effects of DU are determined by factors such as the extent of exposure and whether it was internal or external. Three main pathways exist by which internalization of uranium may occur: inhalation, ingestion, and embedded fragments or shrapnel contamination. Properties such as phase (e.g. particulate or gaseous), oxidation state (e.g. metallic or ceramic), and the solubility of uranium and its compounds influence their absorption, distribution, translocation, elimination and the resulting toxicity. For example, metallic uranium is less toxic compared to hexavalent uranium(VI) uranyl compounds such as uranium trioxide.
|Compilation of 2004 Review Information Regarding Uranium Toxicity|
|Body system||Human studies||Animal studies||In vitro|
|Renal||Elevated levels of protein excretion, urinary catalase and diuresis||Damage to Proximal convoluted tubules, necrotic cells cast from tubular epithelium, glomerular changes||No studies|
|Brain/CNS||Decreased performance on neurocognitive tests||Acute cholinergic toxicity; Dose-dependent accumulation in cortex, midbrain, and vermis; Electrophysiological changes in hippocampus||No studies|
|DNA||Increased reports of cancers||Increased urine mutagenicity and induction of tumors||Binucleated cells with micronuclei, Inhibition of cell cycle kinetics and proliferation; Sister chromatid induction, tumorigenic phenotype|
|Bone/muscle||No studies||Inhibition of periodontal bone formation; and alveolar wound healing||No studies|
|Reproductive||Uranium miners have more first born female children||Moderate to severe focal tubular atrophy; vacuolization of Leydig cells||No studies|
|Lungs/respiratory||No adverse health effects reported||Severe nasal congestion and hemorrage, lung lesions and fibrosis, edema and swelling, lung cancer||No studies|
|Gastrointestinal||Vomiting, diarrhea, albuminuria||n/a||n/a|
|Liver||No effects seen at exposure dose||Fatty livers, focal necrosis||No studies|
|Skin||No exposure assessment data available||Swollen vacuolated epidermal cells, damage to hair follicles and sebaceous glands||No studies|
|Tissues surrounding embedded DU fragments||Elevated uranium urine concentrations||Elevated uranium urine concentrations, perturbations in biochemical and neuropsychological testing||No studies|
|Immune system||Chronic fatigue, rash, ear and eye infections, hair and weight loss, cough. May be due to combined chemical exposure rather than DU alone||No studies||No studies|
|Eyes||No studies||Conjunctivitis, irritation inflammation, edema, ulceration of conjunctival sacs||No studies|
|Blood||No studies||Decrease in RBC count and hemoglobin concentration||No studies|
|Cardiovascular||Myocarditis resulting from the uranium ingestion, which ended 6 months after ingestion||No effects||No studies|
Uranium is pyrophoric when finely divided. It will corrode under the influence of air and water producing insoluble uranium (IV) and soluble uranium (VI) salts. Soluble uranium salts are toxic. Uranium slowly accumulates in several organs, such as the liver, spleen, and kidneys. The World Health Organization has established a daily "tolerated intake" of soluble uranium salts for the general public of 0.5 µg/kg body weight, or 35 µg for a 70 kg adult.
Epidemiological studies and toxicological tests on laboratory animals point to it as being immunotoxic, teratogenic, neurotoxic, with carcinogenic and leukemogenic potential. A 2005 report by epidemiologists concluded: "the human epidemiological evidence is consistent with increased risk of birth defects in offspring of persons exposed to DU."
Early studies of depleted uranium aerosol exposure assumed that uranium combustion product particles would quickly settle out of the air and thus could not affect populations more than a few kilometers from target areas, and that such particles, if inhaled, would remain undissolved in the lung for a great length of time and thus could be detected in urine. Violently burning uranium droplets produce a gaseous vapor comprising about half of the uranium in their original mass. Uranyl ion contamination in uranium oxides has been detected in the residue of DU munitions fires.
Approximately 90 micrograms of natural uranium, on average, exist in the human body as a result of normal intake of water, food and air. Most is in the skeleton. The biochemistry of depleted uranium is the same as natural uranium.
The primary radiation danger from pure depleted uranium is due to alpha particles, which do not travel far through air, and do not penetrate clothing. However, in a matter of a month or so, a sample of pure depleted uranium will generate small amounts of thorium-234 and protactinium-234, which emit the more penetrating beta particles at almost the same rate as the uranium emits alpha rays. This is because uranium-238 decays directly to thorium-234, which with a half-life of 24 days decays to protactinium-234, which in turn decays in a matter of hours to the long-lived uranium-234. A quasi-steady state is therefore reached within a few multiples of 24 days.
Available evidence suggests that the radiation risk is small relative to the chemical hazard.
Surveying the veteran-related evidence pertaining to the Gulf War, a 2001 editorial in the BMJ concluded that it was not possible to justify claims of radiation-induced lung cancer and leukaemia in veterans of that conflict. While agreeing with the editorial's conclusion, a reply noted that its finding in the negative was guaranteed, given that "global dose estimates or results of mathematical modelling are too inaccurate to be used as dose values for an individual veteran", and that, as of April 2001, no practical method of measuring the expected small doses that each individual veteran would receive had been suggested. The author of the reply, a radiation scientist, went on to suggest a method that had been used several times before, including after the 1986 Chernobyl accident. Despite the widespread use of DU in the Iraq War, at least a year after the conflict began, testing for UK troops was still only in the discussion phase.
The Royal Society DU Working Group concluded in 2002 that there were "very low" health risks associated with the use of depleted uranium, though also ventured that, "[i]n extreme conditions and under worst-case assumptions" lung and kidney damage could occur, and that in "worst-case scenarios high local levels of uranium could occur in food or water that could have adverse effects on the kidney". In 2003, the Royal Society issued another urgent call to investigate the actual health and environmental impact of depleted uranium. The same year, a cohort study of Gulf War veterans found no elevated risks of cancer generally, nor of any specific cancers in particular, though recommended follow up studies.
According to the World Health Organization, a radiation dose from it would be about 60% of that from purified natural uranium with the same mass; the radiological dangers are lower due to its longer half-life and the removal of the more radioactive isotopes.
Gulf War syndrome and soldier complaintsEdit
Since 1991, the year the Gulf War ended, veterans and their families voiced concern about subsequent health problems. In 1999, an assessment of the first 1,000 veterans involved in the Ministry of Defence's Gulf War medical assessment programme found "no evidence" of a single illness, physical or mental, that would explain the pattern of symptoms observed in the group. Nevertheless, in 1999, MEDACT petitioned for the WHO to conduct an investigation into illnesses in veterans and Iraqi civilians. A major 2006 review of peer-reviewed literature by a US Institute of Medicine committee concluded that, "[b]ecause the symptoms vary greatly among individuals", they do not point to a syndrome unique to Gulf War veterans, though their report conceded that the lack of objective pre-deployment health data meant definitive conclusions were effectively impossible. Simon Wessely praised the IOM's review, and noted that, despite its central conclusion that no novel syndrome existed, its other findings made it "equally clear that service in the Gulf war did aversely affect health in some personnel". Aside from the lack of baseline data to guide analysis of the veterans' postwar health, because no detailed health screening was carried out when the veterans entered service, another major stumbling block with some studies, like the thousand-veteran one, is that the subjects are self-selected, rather than a random sample, making general conclusions impossible.
Increased rates of immune system disorders and other wide-ranging symptoms, including chronic pain, fatigue and memory loss, have been reported in over one quarter of combat veterans of the 1991 Gulf War. Combustion products from depleted uranium munitions are being considered[needs update] as one of the potential causes by the Research Advisory Committee on Gulf War Veterans' Illnesses, as DU was used in 30 mm and 25 mm cannon rounds on a large scale for the first time in the Gulf War. Veterans of the conflicts in the Persian Gulf, Bosnia and Kosovo have been found to have up to 14 times the usual level of chromosome abnormalities in their genes. Serum-soluble genotoxic teratogens produce congenital disorders, and in white blood cells causes immune system damage.
Human epidemiological evidence is consistent with increased risk of birth defects in the offspring of persons exposed to DU. A 2001 study of 15,000 February 1991 U.S. Gulf War combat veterans and 15,000 control veterans found that the Gulf War veterans were 1.8 (fathers) to 2.8 (mothers) times as likely to have children with birth defects. After examination of children's medical records two years later, the birth defect rate increased by more than 20%:
Dr. Kang found that male Gulf War veterans reported having infants with likely birth defects at twice the rate of non-veterans. Furthermore, female Gulf War veterans were almost three times more likely to report children with birth defects than their non-Gulf counterparts. The numbers changed somewhat with medical records verification. However, Dr. Kang and his colleagues concluded that the risk of birth defects in children of deployed male veterans still was about 2.2 times that of non-deployed veterans.
In early 2004, the UK Pensions Appeal Tribunal Service attributed birth defect claims from a February 1991 Gulf War combat veteran to depleted uranium poisoning. Looking at the risk of children of UK Gulf War veterans suffering genetic diseases such as congenital malformations, commonly called "birth defects", one study found that the overall risk of any malformation was 50% higher in Gulf War veterans as compared to other veterans.
The U.S. Army has commissioned ongoing research into potential risks of depleted uranium and other projectile weapon materials like tungsten, which the U.S. Navy has used in place of DU since 1993. Studies by the U.S. Armed Forces Radiobiology Research Institute conclude that moderate exposures to either depleted uranium or uranium present a significant toxicological threat.
In 2003, Professor Brian Spratt FRS, chairman of the Royal Society's working group on depleted uranium, said: "The question of who carries out the initial monitoring and clean-up is a political rather than scientific question," and "the coalition needs to acknowledge that depleted uranium is a potential hazard and make in-roads into tackling it by being open about where and how much depleted uranium has been deployed."
A 2008 review of all relevant articles appearing in the peer-reviewed journals on MEDLINE through to the end of 2007, including multiple cohort studies of veterans, found no consistent evidence of excess risks of neoplasms that could have some link to DU, and that "[t]he overall incidence of cancers is not increased in the cohort studies of Gulf war and Balkans veterans".
Though a more comprehensive assessment is possible, a 2011 update on a cancer scare regarding Italian soldiers who had served in the Balkans found lower than expected incidence rates for all cancers, a finding "consistent with lacking evidence of an increased cancer incidence among troops of other countries deployed in the areas of Iraq, Bosnia, and Kosovo, where armour-penetrating depleted uranium shells have been used."
One particular subgroup of veterans that may be at higher risk comprises those who have internally retained fragments of DU from shrapnel wounds. A laboratory study on rats produced by the Armed Forces Radiobiology Research Institute showed that, after a study period of 6 months, rats treated with depleted uranium coming from implanted pellets, comparable to the average levels in the urine of Desert Storm veterans with retained DU fragments, had developed a significant tendency to lose weight with respect to the control group.
Substantial amounts of uranium were accumulating in their brains and central nervous systems, and showed a significant reduction of neuronal activity in the hippocampus in response to external stimuli. The conclusions of the study show that brain damage from chronic uranium intoxication is possible at lower doses than previously thought. Results from computer-based neurocognitive tests performed in 1997 showed an association between uranium in the urine and "problematic performance on automated tests assessing performance efficiency and accuracy."
Since 2001, medical personnel at the Basra hospital in southern Iraq have reported a sharp increase in the incidence of child leukemia and genetic malformation among babies born in the decade following the Gulf War. Iraqi doctors attributed these malformations to possible long-term effects of DU, an opinion that was echoed by several newspapers. In 2004, Iraq had the highest mortality rate due to leukemia of any country. In 2003, the Royal Society called for Western militaries to disclose where and how much DU they had used in Iraq so that rigorous, and hopefully conclusive, studies could be undertaken out in affected areas. The International Coalition to Ban Uranium Weapons (ICBUW) likewise urged that an epidemiological study be made in the Basra region, as asked for by Iraqi doctors, but no peer-reviewed study has yet been undertaken in Basra.
A medical survey, "Cancer, Infant Mortality and Birth Sex Ratio in Fallujah, Iraq 2005–2009" published in July 2010, states that the "…increases in cancer and birth defects…are alarmingly high" and that infant mortality 2009/2010 has reached 13.6%. The group compares the dramatic increase, five years after wartime exposure in 2004, with the lymphoma that Italian peacekeepers developed after the Balkan wars and the increased cancer risk in certain parts of Sweden due to the Chernobyl fallout. The origin and time of introduction of the carcinogenic agent causing the genetic stress the group will address in a separate report. The report mentions depleted uranium as one "potentially relevant exposure" but makes no conclusions on the source.
Four studies in the second half of 2012—one of which described the people of Fallujah as having "the highest rate of genetic damage in any population ever studied"—renewed calls for the US and UK to investigate the possible links between their military assault on the city in 2004 and the explosion in deformities, cancers, and other serious health problems. Despite the known use of depleted uranium by allied forces, no depleted uranium has been found in soil samples taken from Fallujah, likely in part due to the fact of such particles being hard to detect as well as a lack of peer-reviewed research on the matter of irradiated soil content.
A 2003 study by the United Nations Environment Programme (UNEP) in Bosnia and Herzegovina stated that low levels of contaminant were found in drinking water and air particulate at DU penetrator impact points. The levels were stated as not a cause for alarm. Yet, Pekka Haavisto, chairman of the UNEP DU projects stated, "The findings of this study stress again the importance of appropriate clean-up and civil protection measures in a post-conflict situation."
A team of Italian scientists from the University of Siena reported in 2005 that, although DU was "clearly" added to the soil in the study area, "the phenomenon was very limited spatially and the total uranium concentrations fell within the natural range of the element in soils. Moreover, the absolute uranium concentrations indicate that there was no contamination of the earthworm species studied."
Contamination as a result of the Afghan WarEdit
The Canadian Uranium Medical Research Centre obtained urine samples from bombed civilian areas in Jalalabad that showed concentrations of 80–400 ng/L of undepleted uranium, far higher than the typical concentration in the British population of ≈5 ng/L.
Studies indicating negligible effectsEdit
Studies in 2005 and earlier have concluded that DU ammunition has no measurable detrimental health effects.
A 1999 literature review conducted by the Rand Corporation stated: "No evidence is documented in the literature of cancer or any other negative health effect related to the radiation received from exposure to depleted or natural uranium, whether inhaled or ingested, even at very high doses," and a RAND report authored by the U.S. Defense department undersecretary charged with evaluating DU hazards considered the debate to be more political than scientific.
A 2001 oncology study concluded that "the present scientific consensus is that DU exposure to humans, in locations where DU ammunition was deployed, is very unlikely to give rise to cancer induction". Former NATO Secretary General Lord Robertson stated in 2001 that "the existing medical consensus is clear. The hazard from depleted uranium is both very limited, and limited to very specific circumstances".
A 2002 study from the Australian defense ministry concluded that "there has been no established increase in mortality or morbidity in workers exposed to uranium in uranium processing industries... studies of Gulf War veterans show that, in those who have retained fragments of depleted uranium following combat related injury, it has been possible to detect elevated urinary uranium levels, but no kidney toxicity or other adverse health effects related to depleted uranium after a decade of follow-up." Pier Roberto Danesi, then-director of the International Atomic Energy Agency (IAEA) Seibersdorf +Laboratory, stated in 2002 that "There is a consensus now that DU does not represent a health threat".
The IAEA reported in 2003 that, "based on credible scientific evidence, there is no proven link between DU exposure and increases in human cancers or other significant health or environmental impacts," although "Like other heavy metals, DU is potentially poisonous. In sufficient amounts, if DU is ingested or inhaled it can be harmful because of its chemical toxicity. High concentration could cause kidney damage." The IAEA concluded that, while depleted uranium is a potential carcinogen, there is no evidence that it has been carcinogenic in humans.
A 2005 study by Sandia National Laboratories' Al Marshall used mathematical models to analyze potential health effects associated with accidental exposure to depleted uranium during the 1991 Gulf War. Marshall's study concluded that the reports of cancer risks from DU exposure are not supported by his analysis nor by veteran medical statistics. Marshall also examined possible genetic effects due to radiation from depleted uranium. Chemical effects, including potential reproductive issues, associated with depleted uranium exposure were discussed in some detail in a subsequent journal paper.
Atmospheric contamination as a result of military actionsEdit
Elevated radiation levels consistent with very low level atmospheric depleted uranium contamination have been found in air samples taken by the UK Atomic Weapons Establishment at several monitoring sites in Britain. These elevated readings appear to coincide with Operation Anaconda in Afghanistan, and the Shock and Awe bombing campaign at the start of the Second Gulf War.
Other contamination casesEdit
On 4 October 1992, an El Al Boeing 747-F cargo aircraft (Flight 1862) crashed into an apartment building in Amsterdam. Local residents and rescue workers complained of various unexplained health issues, which were being attributed to the release of hazardous materials during the crash and subsequent fires. Authorities conducted an epidemiological study in 2000 of those believed to be affected by the accident. The study concluded that there was no evidence to link depleted uranium (used as counterbalance weights on the elevators of the plane) to any of the reported health complaints.
Safety and environmental issuesEdit
About 95% of the depleted uranium produced until now is stored as uranium hexafluoride, (D)UF6, in steel cylinders in open air yards close to enrichment plants. Each cylinder contains up to 12.7 tonnes (or 14 US tons) of UF6. In the U.S. alone, 560,000 tonnes of depleted UF6 had accumulated by 1993. In 2005, 686,500 tonnes in 57,122 storage cylinders were located near Portsmouth, Ohio, Oak Ridge, Tennessee, and Paducah, Kentucky. The long-term storage of DUF6 presents environmental, health, and safety risks because of its chemical instability. When UF6 is exposed to moist air, it reacts with the water in the air and produces UO2F2 (uranyl fluoride) and HF (hydrogen fluoride), both of which are highly soluble and toxic. Storage cylinders must be regularly inspected for signs of corrosion and leaks. The estimated lifetime of the steel cylinders is measured in decades.
There have been several accidents involving uranium hexafluoride in the United States. The vulnerability of DUF6 storage cylinders to terrorist attack is apparently not the subject of public reports. However, the U.S. government has been converting DUF6 to solid uranium oxides for disposal. Disposing of the whole DUF6 inventory could cost anywhere from 15 to 450 million dollars.
- "Figure 1. DU penetrator from the A-10 30mm round". Web.archive.org. 2007-04-12. Archived from the original on 2007-04-12. Retrieved 4 September 2013.
- McDiarmid 2001, p. 123: "Depleted uranium possesses only 60% of the radioactivity of natural uranium, having been 'depleted' of much of its most highly radioactive U234 and U235 isotopes."
- "UN Press Release UNEP/81: Uranium 236 found in depleted uranium penetrators". UN.
- "Properties and Characteristics of DU" U.S. Office of the Secretary of Defense
- Miller & McClain 2007.
- Pattison, Hugtenburg & Green 2010.
- E. S. Craft; A. W. Abu-Qare; M. M. Flaherty; M. C. Garofolo; H. L. Rincavage; M. B. Abou-Donia (2004). "Depleted and natural uranium: chemistry and toxicological effects". Journal of Toxicology and Environmental Health Part B: Critical Reviews. 7 (4): 297–317. PMID 15205046. doi:10.1080/10937400490452714.
- Georgia State University. "Biological Half Lives".
- Mitsakou C., Eleftheriadis K., Housiadas C., Lazaridis M. Modeling of the dispersion of depleted uranium aerosol. 2003 Apr. Retrieved 15 January 2009.
- Hindin, R.; et al. (2005). "Teratogenicity of depleted uranium aerosols: A review from an epidemiological perspective". Environmental Health. 4 (1): 17. PMC . PMID 16124873. doi:10.1186/1476-069X-4-17.
- Peter Diehl (1999). "Depleted Uranium: A By-product of the Nuclear Chain". International Network of Engineers and Scientists Against Proliferation.[dead link]
- Proceedings of American Nuclear Society 2013 Wilmington North Carolina. ANS American Nuclear Society. 2013. OCLC 864923078.
- Douglas Hamilton (25 January 2001). "NATO: 50 Countries See No Depleted Uranium Illness". Reuters Health Information. Archived from the original on 2001-02-20. Retrieved 12 December 2013.
- Deborah Hastings (August 12, 2006). "Is an Armament Sickening U.S. Soldiers?". Associated Press. Archived from the original on 2014-07-03. Retrieved 30 March 2015.
- Oakford, Samuel (14 February 2017). "The United States Used Depleted Uranium in Syria". Foreign Policy. Retrieved 3 March 2017.
- "History of Depleted Uranium and What It Is Used For". Energy Solutions. Retrieved 7 August 2015.
- Depleted uranium WHO Fact sheet N°257, Revised January 2003 Archived 15 August 2012 at the Wayback Machine.
- Plutonium in DU Weapons, a Chronology Dr. Michael Repacholi, WHO
- The Health Effects of Exposure to Uranium and Uranium Weapons Fallout Chris Busby, Documents of the ECRR 2010 No 2
- How much depleted uranium hexafluoride is stored in the United States, anl.gov
- "Depleted UF6 Management Program Documents". Web.ead.anl.gov. Retrieved 4 September 2013.
- "What happens if a cylinder of uranium hexafluoride leaks?". Web.ead.anl.gov. Retrieved 4 September 2013.
- , Overview of Depleted Uranium Hexafluoride Management Program
- Agency review nuclear waste, Cibola County Beacon – News, April 3, 2008
- "FAQ 30-Have there been accidents involving uranium hexafluoride?". Web.ead.anl.gov. Retrieved 4 September 2013.
- "FAQ 22-What is going to happen to the uranium hexafluoride stored in the United States?". Web.ead.anl.gov. Retrieved 4 September 2013.
- "FAQ 27-Are there any currently-operating disposal facilities that can accept all of the depleted uranium oxide that would be generated from conversion of DOE's depleted UF6 inventory?". Web.ead.anl.gov. Retrieved 4 September 2013.
- "Depleted Uranium Inventories". Retrieved 26 February 2016.
- Peacock, H. B. (March 1992). "Pyrophoricity of Uranium" (PDF). Westinghouse Savannah River Company. p. 2. Retrieved 3 May 2015.
- "Primer on Spontaneous Heating and Pyrophoricity" (PDF). United States Department of Energy. 6 January 2015. Retrieved 3 May 2015.
- McManners, Hugh, Gulf War One Real Voices From the Front Line, Ebury Publishing, 2010, ISBN 9780091935986 p91
- Fahey, D. (2003) "Science or Science Fiction? Facts, Myths and Propaganda In the Debate Over Depleted Uranium Weapons" Archived 1 June 2005 at the Wayback Machine., Table 1 on p. 13
- Kalinich, J.F.; et al. (June 2005). "Embedded Weapons-Grade Tungsten Alloy Shrapnel Rapidly Induces Metastatic High-Grade Rhabdomyosarcomas in F344 Rats". Environmental Health Perspectives. 113 (6): 729–734. PMC . PMID 15929896. doi:10.1289/ehp.7791. Archived from the original on 19 January 2009.
- "Depleted Uranium". GlobalSecurity.org. 2011-07-07. Retrieved 2016-07-24.
- The International Legality of the Use of Depleted Uranium Weapons: A Precautionary Approach, Avril McDonald, Jann K. Kleffner and Brigit Toebes, eds. (TMC Asser Press Fall-2003)
- Paul Brown (25 April 2003). "Gulf troops face tests for cancer". theguardian.com. Retrieved 29 August 2013.
- ADVISORY OPINION 1996 July 8; General List No.95 (req: UNGA) Archived 22 May 2014 at the Wayback Machine.. Cornnet.nl. Retrieved 16 January 2011.
- http. //www.houstonprogressive.org. Retrieved 16 January 2011.
- Depleted Uranium UN Resolutions. Prop1.org. Retrieved 16 January 2011.
- International peace and security as an. Unhchr.ch. Retrieved 16 January 2011.
- "Opendocument Sub-Commission resolution 1997/36".
- "Human rights and weapons of mass destruction, or with indiscriminate effect, or of a nature to cause superfluous injury or unnecessary suffering" (PDF). United Nations Economic and Social Council. 27 June 2002.(backup) "In its decision 2001/36 of 16 August 2001, the Sub-Commission, recalling its resolutions 1997/36 and 1997/37 of 28 August 1997, authorized Mr. Y.K.J. Yeung Sik Yuen to prepare, without financial implications, in the context of human rights and humanitarian norms, the working paper originally assigned to Ms. Forero Ucros."
- Joe Sills et al Environmental Crimes in Military Actions and the International Criminal Court (ICC)-United Nations Perspectives (PDF) (HTML) of American Council for the UN University, April 2002. Page 28 Archived 26 March 2009 at the Wayback Machine.
-  Archived 6 August 2009 at the Wayback Machine.
- Gibbons, O.T. (2004) "Uses and Effects of Depleted Uranium Munitions: Towards a Moratorium on Use", Yearbook of International Humanitarian Law, Vol.7, December 2004, pp 191-232 http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=671876
- "ICBUW's membership includes 85 groups in 22 countries worldwide". The International Coalition to Ban Uranium Weapons. 27 September 2006. Retrieved 22 March 2007.
- "Session Document: European Parliament resolution on the harmful effects of unexploded ordnance (landmines and cluster submunitions) and depleted uranium ammunition" (PDF). 10 February 2003. Retrieved 22 March 2007.
- "European Parliament Makes Fourth Call for DU Ban". The International Coalition to Ban Uranium Weapons. 22 November 2006. Retrieved 22 March 2007.
- "DU: Some NATO Countries Reject Moratorium". UN Wire. 11 January 2001. Retrieved 22 March 2007.
- "Depleteduranium – epetition reply". The Prime Minister's Office. 22 March 2007. Retrieved 22 March 2007.
- United Nations General Assembly Session 62 Verbotim Report 61. A/62/PV.61 page 14. The Acting President 5 December 2007. Retrieved 21 August 2008.
- United Nations General Assembly Session 62 Verbotim Report 61. A/62/PV.61 page 25. Mr. De Klerk Netherlands 5 December 2007. Retrieved 21 August 2008.
- Staff. UN Secretary General Publishes Report on Uranium Weapons, ICBUW, 17 September 2008
- UN Department of Public Information: Effects of the use of Armaments and Ammunitions Containing Depleted Uranium (A/C.1/63/L.26) See draft XIV and also Annex XIII
- UK Uranium Weapons Network launched as Belgium becomes first country to ban depleted uranium weapons. Bandepleteduranium.org (2009-06-22). Retrieved 16 January 2011.
- "English translation of Belgian text banning uranium weapons and armour" (PDF). Retrieved 4 September 2013.
- "Belgian Senate votes to ban investments by Belgian financial institutions into uranium weapon manufacturers" (PDF). Retrieved 4 September 2013.
- "Resolución Latinoamericana de la Comision de Derechos Humanos, Justicia y Politicas Carcelarias: Prohibición de las armas de uranio" (PDF). Retrieved 4 September 2013.
- ICBUW. "Costa Rica bans depleted uranium weapons". Bandepleteduranium.org. Retrieved 4 September 2013.
- ICBUW. "Irish depleted uranium ban bill sails through Senate with cross party support". Bandepleteduranium.org. Retrieved 4 September 2013.
- "Oireachtas Web site: Prohibition of Depleted Uranium Weapons Bill 2009". Oireachtas.ie. Retrieved 4 September 2013.
- "UNGA (2012) A/RES/67/36 Resolution adopted by the General Assembly on 3 December 2012, Effects of the use of armaments and ammunitions containing depleted uranium".
- "UNGA (2014) A/RES/69/57 Effects of the use of armaments and ammunitions containing depleted uranium.".
- "ICBUW (2014) The politics behind the vote on 2014’s UN depleted uranium resolution".
- "UNGA (2014) Effects of the use of armaments and ammunitions containing depleted uranium. Report of the Secretary-General.".
- "The INC IR-100 Gamma Ray Camera". Archived from the original on 30 September 2007.
- "Depleted Uranium found as Coloring Matter in Enamel (France)".
- Uijt de Haag P. A., Smetsers R. C., Witlox H. W. and Krus H. W. and Eisenga A.H. (2000). "Evaluating the risk from depleted uranium after the Boeing 747-258F crash in Amsterdam, 1992.". Journal of Hazardous Materials. 76 (1): 39–58. PMID 10863013. doi:10.1016/S0304-3894(00)00183-7.
- "Avoiding or Minimizing Encounters with Aircraft Equipped with Depleted Uranium Balance Weights during Accident Investigations".
- Volvo Ocean Race. "Roaring Forties, chapter 22: France’s inspiration". Volvo Ocean Race. Retrieved 26 February 2016.
- An Experiment at D0 to Study anti-Proton - Proton Collisions at 2-TeV: Design Report.
- "The ZEUS detector: Status Report 1993".
-  Archived 4 September 2011 at the Wayback Machine.
- Agency for Toxic Substances and Disease Registry (1999). "Toxicological profile for uranium". Washington, DC, US Public Health Service.
- RSDUWG 2002a, p. 1. Briefly, inhaled and insoluble means that the DU particles will stick around in the lungs and attendant lymph nodes, presenting a radiological risk; highly soluble means those particles are off to the kidneys, where toxicity is the issue.
- Larry Johnson. "Iraqi cancers, birth defects blamed on U.S. depleted uranium.". Seattle Post-Intelligencer. Archived from the original on 20 November 2008.
- Alex Kirby (1999-06-07). "Depleted uranium: the lingering poison". BBC.
- J.J. Richardson (1999-06-23). "Depleted Uranium: The Invisible Threat". Mother Jones.
- John O'Callaghan (1999-07-30). "Panel says depleted uranium shells leave birth defects, death". Reuters News Service.
- Susan Taylor Martin (2003-05-25). "How harmful is depleted uranium?". St. Petersburg Times.
- Juan Gonzalez (29 September 2004). "The War's Littlest Victim". N.Y. Daily News. Archived from the original on 12 July 2007.
- Health Effects of Uranium. "Toxicological profile for uranium".
- Zwijnenburg 2012.
- Norton-Taylor, Richard (11 January 2001). "MoD knew shells were cancer risk". theguardian.com. Retrieved 29 August 2013.
- Moszynski 2003.
The article quotes Professor Brian Spratt of the Royal Society's DU working group: "It is highly unsatisfactory to deploy a large amount of material that is weakly radioactive and chemically toxic without knowing how much soldiers and civilians have been exposed to."
- Williams, M. (February 9, 2004) "First Award for Depleted Uranium Poisoning Claim," The Herald Online, (Edinburgh: Herald Newspapers, Ltd.)
- Campaign Against Depleted Uranium (Spring, 2004) "MoD Forced to Pay Pension for DU Contamination," CADU News 17
- Miller et al. 2002.
- RSDUWG 2002a, p. 2.
- Livengood 1996, p. 3; RSDUWG 2002a, p. 19.
- «Gmelin Handbuch der anorganischen Chemie» 8th edition, English translation, Gmelin Handbook of Inorganic Chemistry, vol. U-A7 (1982) pp. 300–322.
- Naomi H. Harley; Earnest C. Foulkes; Lee H. Hilborne; Arlene Hudson; C. Ross Anthony (1999). A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Volume 7 – Depleted Uranium (PDF). Washington, DC: National Defense Research Institute, RAND. pp. 1–12. ISBN 978-0-8330-2681-1. MR-1018/7-OSD. (an HTML copy of the text is also available, as part of Rostker, B. (2000) Depleted Uranium in the Gulf (II) Environmental Exposure Reports Tech. Rep. No. 2000179-2 (Washington, DC: Special Assistant for Gulf War Illnesses, Department of Defense)), citing Army Environmental Policy Institute (June 1995) "Health and Environmental Consequences of Depleted Uranium Use in the US Army," (Champaign, Illinois) and U.S. Army Center for Health Promotion and Preventive Medicine (1998) "Interim Summary, Total Uranium and Isotope Uranium Results" (Operation Southern Watch) CHPPM Project No. 47-EM-8111-98.
- US Dept. of Energy Handbook, "Primer on Spontaneous Heating and Pyrophoricity", Chapter "Uranium"
- Wan B.; Fleming J.; Schultz T.; Sayler G. (2006). "In vitro immune toxicity of depleted uranium: effects on murine macrophages, CD4+ T cells, and gene expression profiles". Environmental Health Perspectives. 114 (1): 85–91. PMC . PMID 16393663. doi:10.1289/ehp.8085.
- Arfsten D. P.; Still K. R.; Ritchie G. D. (2001). "A review of the effects of uranium and depleted uranium exposure on reproduction and fetal development". Toxicology & Industrial Health. 17 (5–10): 180–91. PMID 12539863. doi:10.1191/0748233701th111oa.
- Domingo J. L. (2001). "Reproductive and developmental toxicity of natural and depleted uranium: a review". Reproductive Toxicology. 15 (6): 603–9. PMID 11738513. doi:10.1016/S0890-6238(01)00181-2.
- Briner W.; Murray J. (2005). "Effects of short-term and long-term depleted uranium exposure on open-field behavior and brain lipid oxidation in rats". Neurotoxicology and Teratology. 27 (1): 135–44. PMID 15681127. doi:10.1016/j.ntt.2004.09.001.
- A. C. Miller; D. Beltran; R. Rivas; M. Stewart; R. J. Merlot; P. B. Lison (June 2005). Radiation- and Depleted Uranium-Induced Carcinogenesis Studies: Characterization of the Carcinogenic Process and Development of Medical Countermeasures (PDF). CD 05-2. Armed Forces Radiobiology Research Institute. NATO RTG-099 2005. Archived from the original (PDF) on 7 February 2012.
- Rostker, B. (2000) "Research Report Summaries," Depleted Uranium in the Gulf (II) Environmental Exposure Report no. 2000179-2, Office of the Special Assistant for Gulf War Illnesses, Department of Defense.
- Mitsakou et al. 2003
- Horan, P.; Dietz, L.; Durakovic, A. (August 2002). "The quantitative analysis of depleted uranium isotopes in British, Canadian, and U.S. Gulf War veterans". Military medicine. 167 (8): 620–7. PMID 12188230.
- Carter, R. F.; Stewart, K. (1970). "On the oxide fume formed by the combustion of plutonium and uranium". Inhaled particles. 2: 819–38. PMID 5527739.
- Salbu, B.; Janssens, K.; Lind, O. C.; Proost, K.; Gijsels, L.; Danesi, P. R. (2005). "Oxidation states of uranium in depleted uranium particles from Kuwait". Journal of Environmental Radioactivity. 78 (2): 125–135. PMID 15511555. doi:10.1016/j.jenvrad.2004.04.001.
- Rostker, B. (2000) "Depleted Uranium in the Gulf (II)" Archived 12 April 2007 at the Wayback Machine. Environmental Exposure Reports Tech. Rep. No. 2000179-2 (Washington, DC: Special Assistant for Gulf War Illnesses, Department of Defense)
- The amounts of both thorium-234 and protactinium-234 after the first days and for millions of years thereafter will be approximately proportional to 1−2 −t / (24 days). See Kenneth S. Krane (1988). Introductory Nuclear Physics. ISBN 978-0-471-80553-3.
- McDiarmid 2001.
- Mould 2001.
Mould's suggestion was electron paramagnetic resonance dosimetry using tooth enamel. He also wrote that the US National Institute of Standards and Technology was able, using this method, to measure doses as low as 20 mSv, and that, if it were asked to, the NIST would be able to get involved, meaning at least one centre could help undertake a screening programme for veterans.
- Greenberg et al. 2004, which found that perhaps a quarter of all UK troops would have been interested in undergoing DU-related monitoring, although "the desire for DU screening is more closely linked to current health status rather than plausible exposure to DU."
Confusingly, Moszynski 2003 reports that "testing is now available to all troops that served in Iraq", and does not say if this is testing à la Mould.
- The study is mentioned by Patel 2006.
According to Patel, "[t]he majority evidence and expert opinion on the lack of a clear association between depleted uranium are quite consistent". Similarly, Murphy, Greenberg & Bland 2009: "[T]here is now a large body of evidence to suggest that, whatever the cause of the ill‐health experienced by Gulf War veterans, neither DU nor vaccinations are likely to have caused them."
The Working Group study he mentions is Royal Society DU Working Group 2002b, which is a summary of the second part of the Working Group's look at the health effects of DU: Part 1: RSDUWG 2001; Part 2: RSDUWG 2002a.
- Macfarlane et al. 2003: "There is no current excess risk of cancer overall nor of site specific cancers in Gulf war veterans. Specific exposures during deployment have not resulted in a subsequent increased risk of cancer. The long latent period for cancer, however, necessitates the continued follow up of these cohorts."
- I. Al-Sadoon, et al., writing in the Medical Journal of Basrah University, (see Table 1 here) Archived 28 September 2011 at the Wayback Machine.. This version from data by same author(s) in Wilcock, A. R., ed. (2004) "Uranium in the Wind" (Ontario: Pandora Press) ISBN 0-9736153-2-X
- Murphy 1999.
- Coker et al. 1999: "As the veterans assessed by the programme were all self selected, the prevalence of illness in Gulf war veterans cannot be determined from this study. Furthermore, it is not known whether the veterans in this study were representative of sick veterans as a group."
To recapitulate using Murphy 1999: "[T]hough Gulf War veterans' illnesses are real and sometimes disabling, they do not seem to constitute a unique illness."
- Stott & Holdstock 1999.
- Charatan 2006. The quote is of Lynn Goldman, who chaired the IOM committee that carried out the review.
Iversen, Chalder & Wessely 2007 notes that "despite clear evidence of an increase in symptom burden and a decrease in well being" among Gulf War veterans, "exhaustive clinical and laboratory based scientific research has failed to document many reproducible biomedical abnormalities in this group. Likewise, there has been no evidence of an increase in disease related mortality".
- Charatan 2006. The quote is of Wessely himself.
- Coker et al. 1999; Murphy 1999.
- U.S. Research Advisory Committee on Gulf War Veterans' Illnesses (2004) "Scientific Progress in Understanding Gulf War Veterans' Illnesses: Report and Recommendations"
- Murphy, Greenberg & Bland 2009: "Metallic DU is weakly radioactive and therefore contact with unbroken skin is an extremely low risk to health. However, when a DU round strikes an armoured target, it undergoes spontaneous partial combustion resulting in a fine aerosol of largely insoluble uranium oxides. Presence of this aerosol elevates the risk of potentially chemotoxic or radiotoxic exposure via inhalation or ingestion".
- Fleming, N.; Townsend, M. (11 August 2002). "Gulf veteran babies 'risk deformities' ". The Observer. London. Retrieved 29 August 2013.
- Arfsten D. P.; Still K. R.; Ritchie G. D. (2001). "A review of the effects of uranium and depleted uranium exposure on reproduction and fetal development". Toxicology and Industrial Health. 17 (5–10): 180–191. PMID 12539863. doi:10.1191/0748233701th111oa.
- Schröder H.; Heimers A.; Frentzel-Beyme R.; Schott A.; Hoffman W. (2003). "Chromosome Aberration Analysis in Peripheral Lymphocytes of Gulf War and Balkans War Veterans" (PDF). Radiation Protection Dosimetry. 103 (3): 211–219. PMID 12678382. doi:10.1093/oxfordjournals.rpd.a006135.
- Kang, H.; et al. (2001). "Pregnancy Outcomes Among U.S. Gulf War Veterans: A Population-Based Survey of 30,000 Veterans". Annals of Epidemiology. 11 (7): 504–511. PMID 11557183. doi:10.1016/S1047-2797(01)00245-9.
- Department of Veterans Affairs (2003). "Q's & A's – New Information Regarding Birth Defects" (PDF). Gulf War Review. 12 (1): 10. Archived from the original (PDF) on 2006-09-29.
- "Gulf soldier wins pension fight". BBC News. 2004-02-02.
- Ian Sample; Nic Fleming (17 April 2003). "When the dust settleslink". London: theguardian.com. Retrieved 29 August 2013.
- Doyle et al. 2004
- D. E. McClain; A. C. Miller; J. F. Kalinich (June 2005). Status of Health Concerns about Military Use of Depleted Uranium and Surrogate Metals in Armor-Penetrating Munitions (PDF). CD 05-2. Armed Forces Radiobiology Research Institute. Archived from the original (PDF) on 7 February 2012.
- Lagorio, Grande & Martina 2008.
- Peragallo et al. 2011: "[T]he excess of reported cases for this malignancy [lymphoma] in 2001–2002 was probably due to a peak that occurred in 2000 among the whole military; it is therefore unrelated to deployment in the Balkans, and probably represents a chance event."
- T. C. Pellmar; J. B. Hogan; K. A. Benson; M. R. Landauer (February 1998). Toxicological Evaluation of Depleted Uranium in Rats: Six Month Evaluation Point (PDF). Armed Forces Radiobiology Research Institute. AFRRI Special Publication 98-1. Archived from the original (PDF) on 7 February 2012.
- Bordujenko, A. (September 2002). "Military medical aspects of depleted uranium munitions" (PDF). ADF Health. Australian Defence Forces. 3.
- Elizabeth Neuffer Iraqis Trace Surge in Cancer to US Bombings Archived 2 September 2013 at the Wayback Machine. Boston Globe January 26, 2003, Page: A11 Section: National/Foreign
- Larry Johnson Iraqi cancers, birth defects blamed on U.S. depleted uranium Archived 20 November 2008 at the Wayback Machine. Seattle Post-Intelligencer November 12, 2002. Retrieved 25 January 2009.
- Ron McKay (14 January 2001). "Depleted Uranium: The Horrific Legacy of Basra". Sunday Herald. Scotland. Archived from the original on 27 May 2013. Retrieved February 15, 2013.
- "WHO Data, 2004". Retrieved 4 September 2013.
- Moszynski 2003.
- Support the Basra Epidemiological Study, International Coalition to Ban Uranium Weapons
- Mantelero_Depleted uranium legal aspects (Italy)2009-2011 7-05-2011
- Cancer, Infant Mortality and Birth Sex-Ratio in Fallujah, Iraq, 2005–2009, By Chris Busby, Malak Hamdan and Enteser Ariabi, International Journal of Environmental Research and Public Health July 2010, ISSN 1660-4601. Article is also here .
- Caputi, Ross (25 October 2012). "The victims of Fallujah's health crisis are stifled by western silence". theguardian.com. Retrieved 29 August 2013.
- Fathi et al. 2013
- Fisk, Robert (26 April 2012). "Robert Fisk: The Children of Fallujah - families fight back". independent.co.uk/. Retrieved 29 February 2016.
- Report of the WHO's Depleted Uranium Mission to Kosovo (pdf 123kb) January 22–31, 2001
- Low-level DU contamination found in Bosnia and Herzegovina, UNEP calls for precaution United Nations Environment Programme, 25 March 2003. Retrieved 25 January 2009.
- Di Lella et al. 2005
- Durakovic, A. (2005). "The Quantitative Analysis of Uranium Isotopes in the Urine of the Civilian Population of Eastern Afghanistan after Operation Enduring Freedom". Military Medicine. 170 (4): 277–284.
- ""A Review of the Scientific Literature as it Pertains to Gulf War Illnesses," Rand Report, 1999.".
- Bernard D. Rostker Depleted Uranium, A Case Study of Good and Evil. RAND Corporation
- James P. Mc Laughin; Michael P. R. Waligorski (2001). "Depleted Uranium – A Health, Environmental or Societal Issue?" (PDF). Archive of Oncology. 9 (4): 213.
- "NATO Press Conference on Depleted Uranium". Nato.int. Retrieved 4 September 2013.
- Military medical aspects of depleted uranium munitions Archived 19 July 2015 at the Wayback Machine.
- Richard Stone (2002-09-13). "Environmental Radioactivity: New Findings Allay Concerns Over Depleted Uranium". Science Magazine.
- "IAEA Depleted Uranium Factsheet".
- An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study Archived 4 February 2012 at the Wayback Machine., Albert C. Marshall, Sandia National Laboratories
- Marshall, A. C. Gulf war depleted uranium risks Journal of Exposure Science and Environmental Epidemiology 18, 95–108 (January 2008) | doi:10.1038/sj.jes.7500551
-  Archived 21 March 2012 at the Wayback Machine.
- C. Busby and S. Morgan, 2006, Did the Use of Uranium Weapons in Gulf War 2 Result in Contamination of Europe? Evidence from the Measurements of the Atomic Weapons Establishment, Aldermaston, Aberystwyth, Green Audit.
- "FAQ 16-How much depleted uranium hexafluoride is stored in the United States?". Web.ead.anl.gov. Retrieved 21 August 2013.
- "Documents". Web.ead.anl.gov. Retrieved 21 August 2013.
- "» Science-Based Stockpile Stewardship (Vol. 5, No. 2)". Retrieved 26 February 2016.
- "FAQ 30-Have there been accidents involving uranium hexafluoride?". Web.ead.anl.gov. Retrieved 21 August 2013.
- "FAQ 22-What is going to happen to the uranium hexafluoride stored in the United States?". Web.ead.anl.gov. Retrieved 21 August 2013.
- "FAQ 27-Are there any currently-operating disposal facilities that can accept all of the depleted uranium oxide that would be generated from conversion of DOE's depleted UF6 inventory?". Web.ead.anl.gov. Retrieved 21 August 2013.
- Al-Sabbak, M.; Sadik Ali, S.; Savabi, O.; Savabi, G.; Dastgiri, S.; Savabieasfahani, M. (2012). "Metal Contamination and the Epidemic of Congenital Birth Defects in Iraqi Cities" (PDF). Bulletin of Environmental Contamination and Toxicology. 89 (5): 937–944. PMC . PMID 22983726. doi:10.1007/s00128-012-0817-2.
- Brown, Mark (2006). "Toxicological assessments of Gulf War veterans". Philosophical Transactions of the Royal Society. 361: 649–679. JSTOR 20209668. PMC . PMID 16687269. doi:10.1098/rstb.2006.1825.
- Charatan, Fred (2006). "Gulf war symptoms do not constitute a syndrome". BMJ. 333: 618. JSTOR 40700302. doi:10.1136/bmj.333.7569.618-b.
- Coker, W. J.; Bhatt, B. M.; Blatchley, N. F.; Graham, J. T. (1999). "Clinical findings for the first 1000 Gulf war veterans in the Ministry of Defence's medical assessment programme". BMJ. 318: 290–294. JSTOR 25181700. doi:10.1136/bmj.318.7179.290.
- Di Lella, L. A.; Nannoni, F.; Protano, G.; Riccobono, F. (2005). "Uranium contents and atom ratios in soil and earthworms in western Kosovo after the 1999 war". Science of the Total Environment. 337 (1–3): 109–118. doi:10.1016/j.scitotenv.2004.07.001.
- Dorsey, Carrie D.; Engelhardt, Susan M.; Squibb, Katherine S.; McDiarmid, Melissa A. (2009). "Biological Monitoring for Depleted Uranium Exposure in U.S. Veterans". Environmental Health Perspectives. 117 (6): 953–956. JSTOR 25549605. doi:10.1289/ehp.0800413.
- Doyle, P.; MacOnochie, N.; Davies, G.; MacOnochie, I.; Pelerin, M.; Prior, S.; Lewis, S. (2004). "Miscarriage, stillbirth and congenital malformation in the offspring of UK veterans of the first Gulf war". International Journal of Epidemiology. 33 (1): 74–86. PMID 15075150. doi:10.1093/ije/dyh049.
- Fathi, R. A.; Matti, L. Y.; Al-Salih, H. S.; Godbold, D. (2013). "Environmental pollution by depleted uranium in Iraq with special reference to Mosul and possible effects on cancer and birth defect rates". Medicine, Conflict and Survival. 29 (1): 7–25. doi:10.1080/13623699.2013.765173.
- Greenberg, Neil; Iversen, Amy C.; Unwin, Catherin; Hull, L.; Wessely, S. (2004). "Screening for depleted uranium in the United Kingdom armed forces: who wants it and why?". Journal of Epidemiology and Community Health. 58: 558–561. doi:10.1136/jech.2003.014142.
- Iversen, Amy; Chalder, Trudie; Wessely, Simon (2007). "Gulf War Illness: Lessons from medically unexplained symptoms". Clinical Psychology Review. 27 (7): 842–854. PMID 17707114. doi:10.1016/j.cpr.2007.07.006.
- Lagorio, S.; Grande, E.; Martina, L. (2008). "Review of epidemiological studies of cancer risk among Gulf War and Balkans veterans". Epidemiologia e Prevenzione. 32 (3, number 3): 145–155. PMID 18828552.
- Livengood, David R. (1996). "Introduction to the Problem". In David R. Livengood,. Health Effects of Embedded Depleted Uranium Fragments (PDF). Bethesda, Maryland: Armed Forces Radiobiology Research Institute. pp. 3–6.
- Macfarlane, Gary J.; Biggs, Anne-Marie; Maconochie, Noreen; Hotopf, Matthew; Doyle, Patricia; Lunt, Mark (2003). "Incidence of cancer among UK Gulf War veterans: cohort study". BMJ. 327: 1373–1375. JSTOR 25458017. doi:10.1136/bmj.327.7428.1373.
- McDiarmid, Melissa A. (2001). "Depleted uranium and public health: Fifty years' study of occupational exposure provides little evidence of cancer". BMJ. 322: 123–124. JSTOR 25466001. PMC . PMID 11159557. doi:10.1136/bmj.322.7279.123.
- Miller, A. C.; McClain, D. (2007). "A Review of Depleted Uranium Biological Effects: In Vitro and In Vivo Studies". Reviews on Environmental Health. 22 (1): 75–89. PMID 17508699. doi:10.1515/REVEH.2007.22.1.75.
- Miller, A. C.; Stewart, M.; Brooks, K.; Shi, L.; Page, N. (2002). "Depleted uranium-catalyzed oxidative DNA damage: absence of significant alpha particle decay". Journal of Inorganic Biochemistry. 91 (1): 246–252. PMID 12121782. doi:10.1016/S0162-0134(02)00391-4.
- Mitsakou, C.; Eleftheriadis, K.; Housiadas, C.; Lazaridis, M. (2003). "Modeling of the dispersion of depleted uranium aerosol". Health Physics. 84 (4): 538–544. PMID 12705453. doi:10.1097/00004032-200304000-00014.
- Moszynski, Peter (2003). "Royal Society warns of risks from depleted uranium". BMJ. 326: 952. JSTOR 25454350. doi:10.1136/bmj.326.7396.952.
- Mould, Richard F. (2001). "Radiation dose from depleted uranium can now be measured". BMJ. 322: 865–866. JSTOR 25466697. doi:10.1136/bmj.322.7290.865/a.
- Murphy, Frances M. (1999). "Gulf war syndrome: There may be no specific syndrome, but troops suffer after most wars". BMJ. 318: 274–275. JSTOR 25181681. doi:10.1136/bmj.318.7179.274.
- Murphy, Dominic; Greenberg, Neil; Bland, Duncan (2009). "Health concerns in UK Armed Forces personnel". Journal of the Royal Society of Medicine. 102 (4): 143–147. doi:10.1258/jrsm.2009.080387.
- Patel, Amit (2006). "No strong link between depleted uranium and cancer". BMJ. 333: 971. JSTOR 40700763. PMC . PMID 17082557. doi:10.1136/bmj.333.7575.971-b.
- Pattison, John E.; Hugtenburg, Richard P.; Green, Stuart (2010). "Enhancement of Natural Background Gamma-radiation Dose around Uranium Micro-particles in the Human Body". Journal of the Royal Society Interface. 7 (45): 603–611. doi:10.1098/rsif.2009.0300.
- Peragallo, M. S.; Urbano, F.; Sarnicola, G.; Lista, F.; Vecchione, A. (2011). "Cancer incidence in the military: an update". Epidemiologia e Prevenzione. 35 (5-6, number 5–6): 339–345. PMID 22166781.
- Royal Society Working Group on the health hazards of depleted uranium munitions (2001). "The health hazards of depleted uranium munitions: Part I". London: The Royal Society.
- ——— (2002a). "The health hazards of depleted uranium munitions: Part II". London: The Royal Society.
- ——— (2002b). "The health effects of depleted uranium munitions: a summary". Journal of Radiological Protection. 22 (2): 131–139. doi:10.1088/0952-4746/22/2/301.
- Squibb, Katherine S.; McDiarmid, Melissa A. (2006). "Depleted uranium exposure and health effects in Gulf War veterans". Philosophical Transactions of the Royal Society. 361: 639–648. JSTOR 20209667. doi:10.1098/rstb.2006.1823.
- Stott, Robin; Holdstock, Douglas (1999). "WHO should undertake full inquiry into Gulf war illness". BMJ. 318: 1422. JSTOR 25184732. doi:10.1136/bmj.318.7195.1422a.
- Zwijnenburg, Wim (2012). Hazard Aware: Lessons learned from military field manuals on depleted uranium and how to move forward for civilian protection norms (PDF). Utrecht: IKV Pax Christi. ISBN 978-9-070-44327-6.
|Look up depleted uranium in Wiktionary, the free dictionary.|
|Wikimedia Commons has media related to Depleted uranium.|
- United Nations
- "Human rights and weapons of mass destruction, or with indiscriminate effect, or of a nature to cause superfluous injury or unnecessary suffering"
(The UN 2002 report)
- Depleted Uranium and the IAEA
- Scientific reports
- ATSDR – Case Studies in Environmental Medicine (CSEM): Uranium Toxicity U.S. Department of Health and Human Services
- "Depleted Uranium in Bosnia and Herzegovina – Postconflict Assessment" by UN Environment Programme
- "Radiological Conditions in Areas of Kuwait With Residues of Depleted Uranium" by International Atomic Energy Agency
- "Technical Report on Capacity-building for the Assessment of Depleted Uranium in Iraq" by UN Environment Programme
- "A Review of the Scientific Literature As It Pertains to Gulf War Illnesses" by RAND
- Depleted Uranium article from the Royal Society
- An Analysis of Uranium Dispersal and Health Effects Using a Gulf War Case Study by Sandia National Laboratories
- Depleted Uranium Human Health Fact Sheet by Argonne National Laboratory Environmental Assessment Division
- Depleted uranium (DU) normative value pilot study: levels of uranium in urine samples from the general population by AD Jones, BG Miller S Walker, J Anderson, AP Colvin, PA Hutchison, CA Soutar. IOM Research Report TM/05/03
- A normative study of levels of uranium in the urine of personnel in the British Forces by BG Miller, AP Colvin, PA Hutchison, H Tait, S Dempsey, D Lewis, CA Soutar. IOM Research Report TM/05/08
- Opinion on the environmental and health risks posed by depleted uranium by the Scientific Committee on Health and Environmental Risks (SCHER)